Medical Marketing & Media

What to make of the FDA’s increased focus on pharma’s social media ads

If the crackdown on pharma’s TV ads and subsequent extension to social media has underscored anything, it’s that brands need ...
Fierce Pharma

Bayer earns FDA untitled letter for Nubeqa's 'attention-grabbing visuals'

The FDA has reprimanded Bayer for the “attention-grabbing visuals” and “frequent scene changes” in ads for the company’s ...
MM&M

ESPN made a faux pharma ad. So MM+M wrote it an untitled letter

Given the copious rules and regulations placed on pharma DTC ads, it’s no wonder tropes abound in the space. And tropes, of course, make things easy to spoof. (Who can forget the faux-warning, “May ...
RAPS

FDA posts more than 100 warning and untitled letters in ad crackdown

The US Food and Drug Administration (FDA) has published scores of warning letters, most of them to companies for marketing and advertising compounded versions of glucagon-like peptide-1 (GLP-1) ...
Honolulu Star-Advertiser

Letter: Noem’s ad campaign was bridge too far for Trump

Select an option below to continue reading this premium story. Already a Honolulu Star-Advertiser subscriber? Log in now to continue reading. The Honolulu Star-Advertiser welcomes all opinions. Want ...
STAT

Pharmalittle: We’re reading about FDA letters targeting drug ads, a U.S. investment by GSK, and more

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...
The Virginian-Pilot

Letters for Aug. 10: Miyares demonstrated poor judgment in political ad

Jason Miyares’ running of a misleading and distasteful ad politicizing the tragic death of Lindsey Braun is an unfortunate strike against his bid for re-election as attorney general. Braun was ...